Sort
82,697 grants matching “vaccine development”
Community-Centered Interventions for Improved Vaccine Uptake for COVID (CIVIC)
$697,711Erica E Marsh · University Of Michigan At Ann Arbor · R01 · FY2023 · MD
Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform
$697,695Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2024 · AI
Accelerating Malaria Vaccines with a Custom Preclinical Humanized Mouse Model Platform
$697,695Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2025 · AI
Risk Factors for AIDS among Drug Users: Getting Close to Zero
$697,615Don C Des Jarlais · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · DA
Discovering the essential genome of Plasmodium falciparum
$697,594John Adams · University Of South Florida · R01 · FY2018 · AI
NRSA Institutional Training Program in Oral Biology
$697,564William P McArthur · University Of Florida · T32 · FY2007 · DE
Clinical analysis and therapeutic development of exosomal ACE2
$697,517Huiping Liu · Northwestern University At Chicago · R01 · FY2025 · AI
Clinical analysis and therapeutic development of exosomal ACE2
$697,517Huiping Liu · Northwestern University At Chicago · R01 · FY2024 · AI
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
$697,498William Gerald Teague · University Of Virginia · R01 · FY2024 · AI
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$697,497Peter G Szilagyi · University Of California Los Angeles · R01 · FY2018 · AI
A Novel Prime/Pull Therapeutic Vaccine Strategy to Prevent Recurrent Genital Herpes
$697,459Lbachir Benmohamed · University Of California-Irvine · R01 · FY2020 · AI
Adolescent health behaviors in the time of COVID-19
$697,455Michele Ybarra · Center For Innovative Public Health Research · R01 · FY2023 · HD
Optimizing IMPDH inhibitors for the treatment of cryptosporidiosis
$697,416Gregory D Cuny · University Of Houston · R56 · FY2014 · AI
Chicago Clinical Trials Unit
$697,341Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2023 · AI
Pathogenesis of Burkholderia mallei and pseudomallei
$697,335Frank Gherardini · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
The Protective and Pathologic Features of the EVD Survivor Immune System
$697,315William Fischer · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Bi-functional Polymer-Attached Inhibitors of Influenza Viruses
$697,295Jianzhu Chen · Massachusetts Institute Of Technology · U01 · FY2007 · AI
24/7 Training: Improving HIV Prevention for African American Youth
$697,175Regina Firpo-Triplett · Monarch Media, Inc. · R44 · FY2011 · MH
Non-canonical epitope presentation and antigen processing by MHC-E
$697,170Klaus J Frueh · Oregon Health & Science University · R01 · FY2025 · AI
Molecular Pharmacology of NKT Cell Agonists
$697,142Luc Teyton · Scripps Research Institute, The · R01 · FY2013 · AI
Conformational Landscape of the HIV-1 Envelope Glycoproteins
$697,140Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2017 · AI
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum
$697,101Prakash Srinivasan · Johns Hopkins University · R01 · FY2025 · AI
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
$697,088Christopher L King · Case Western Reserve University · R01 · FY2024 · AI
HIV neutralization and mechanisms of cellular entry
$697,073Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Quantifying Immune VS. Viral Killing of SIV Infected and Latently Infected Cells
$697,062Ruy M Ribeiro · Los Alamos Nat Secty-Los Alamos Nat Lab · R01 · FY2016 · AI